(Q35784527)

10 August 2017

1 reference

title

Moving towards individualized medicine with pharmacogenomics (English)

1 reference

10 August 2017

1 reference

William E Evans

1

1 reference

10 August 2017

Mary V Relling

series ordinal

2

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 May 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

429

1 reference

10 August 2017

issue

6990

1 reference

10 August 2017

page(s)

464-468

1 reference

https://scigraph.springernature.com/pub.10.1038/nature02626

10 August 2017

exact match

0 references

cites work

Pharmacogenomics: translating functional genomics into rational therapeutics

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02626

Pharmacogenetic perspectives gained from twin and family studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02626

Molecular mechanisms of genetic polymorphisms of drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02626

Characterization of the common genetic defect in humans deficient in debrisoquine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02626

Pharmacogenomics: the inherited basis for interindividual differences in drug response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02626

Inheritance and drug response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02626

Pharmacogenomics--drug disposition, drug targets, and side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02626

Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02626

Altered mercaptopurine metabolism, toxic effects, and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02626

Preventing Toxicity With a Gene Test

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02626

With your genes? Take one of these, three times a day

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02626

Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02626

Polymorphic hydroxylation of Debrisoquine in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02626

Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02626

Treatment-specific changes in gene expression discriminate in vivo drug response in human leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02626

Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02626

Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02626

Genetic structure of human populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02626

The importance of race and ethnic background in biomedical research and clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02626

Genetic testing for BRCA1 mutation in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02626

Indexing pharmacogenetic knowledge on the World Wide Web.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02626

Pharmacogenetics goes genomic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02626

Clinical proteomics: personalized molecular medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02626

7 January 2021

Mining the genome for combination therapies

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02626

7 January 2021

Gene expression-based high-throughput screening(GE-HTS) and application to leukemia differentiation

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02626

7 January 2021

Gene expression as a drug discovery tool

1 reference

https://api.crossref.org/works/10.1038%2FNATURE02626

7 January 2021

https://api.crossref.org/works/10.1038%2FNATURE02626

1 reference

7 January 2021

Identifiers

DOI

10.1038/NATURE02626

1 reference

Dimensions Publication ID

10 August 2017

1027752505

0 references

1 reference